Rezolute's Phase 3 sunRIZE Study for Ersodetug Fails to Meet Primary and Secondary Endpoints Despite Analyst Backing
Rezolute Inc. (NASDAQ:RZLT) is one of the best biotech penny stocks to buy according to analysts.
Rezolute Inc. (RZLT)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 9,180,000 | $27,999,000 | 0.3% | |
| 2. | Opaleye Management James A. Silverman | 6,300,000 | $19,215,000 | +1% | 2.53% |
| 3. | Balyasny Asset Management Dmitry Balyasny | 5,048,421 | $15,397,684 | +13% | 0.02% |
| 4. | Siren L.L.C. Raymond Debbane | 3,328,287 | $10,151,275 | 0.28% | |
| 5. | Integral Health Asset Management Bhagwan Jay Rao | 2,000,000 | $6,100,000 | 0.29% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.85 | 10,000 | $28,500.00 | 414,462 | 2026-03-30 | Filing | |
| $1.69 | 5,650 | $9,548.50 | 119,675 | 2025-12-16 | Filing | |
| $1.70 | 28,000 | $47,600.00 | 308,352 | 2025-12-16 | Filing | |
| $1.79 | 2,500 | $4,475.00 | 7,000 | 2025-12-15 | Filing | |
| $1.79 | 2,500 | $4,462.50 | 7,000 | 2025-12-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 842,949 | $0.00 | 0 | 2015-02-09 | Filing | |
| $0.08 | 893,750 | $75,075.00 | 0 | 2012-09-04 | Filing | |
| $0.08 | 10,000 | $840.00 | 0 | 2012-09-04 | Filing | |
| $0.08 | 893,750 | $75,075.00 | 0 | 2012-09-04 | Filing | |
| $0.08 | 893,750 | $75,075.00 | 0 | 2012-09-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,990,659 | $39,621,510 | 0.06% | |
| 2. | 6,313,503 | $19,256,184 | 0% | |
| 3. | 3,522,080 | $10,742,344 | 0% | |
| 4. | 3,438,881 | $10,488,586 | 0.01% | |
| 5. | 2,981,765 | $9,094,383 | 0% |
News See All
10 Best Biotech Penny Stocks to Buy According to Analysts
On December 24, Jared Holz of Mizuho joined 'Power Lunch' on CNBC to talk about how to play biotech moving into 2026.
Is Rezolute Inc. (RZLT) One of the Top Long-Term Biotechnology Stocks to Buy
Rezolute Inc. (NASDAQ:RZLT) is one of the top long-term biotechnology stocks to buy. Wedbush analyst Yun Zhong reaffirmed a Buy rating on Rezolute Inc.
Top 8 Long-Term Biotechnology Stocks to Buy
Momentum in biotechnology stocks is accelerating after years of underperformance.
13 Best Multibagger Stocks to Invest in Now
The global economic and geopolitical environment in 2025 is marked by uncertainty, trade tensions, and shifting monetary policies.
10 Best Multibagger Stocks To Buy Heading into 2025
November has been an eventful month so far for the market as the Fed cut rates by a quarter percentage and president-elect, Donald Trump won the election for the second time.
Insiders are Piling into These 5 Healthcare Stocks in 2024
This article presents an overview of Insiders are Piling into These 5 Healthcare Stocks in 2024. For a detailed overview of such stocks read our article, Insiders are Piling into These 10 Healthcare...
Insiders Are Buying These 5 Penny Stocks
Maryland-based biotechnology company Gain Therapeutics Inc (NASDAQ:GANX) ranks fifth in our list of the penny stocks with latest insider purchases.
Is Rezolute, Inc. (RZLT) A Good Stock To Buy?
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...
Hedge Fund Resource Center